Chinese Pharma Major Offloads 75.05 Lakh Shares in Gland Pharma Through Block Deals on BSE
New Delhi (Economy India): Chinese pharmaceutical major Fosun Pharma has pared its stake in Gland Pharma by selling a 4.55 per cent holding for approximately Rs 2,121.50 crore through a series of block deals on the BSE.
Fosun Pharma Industrial Pte Ltd, one of the promoters of Hyderabad-based Gland Pharma, sold 75,05,500 shares of the company in 11 separate tranches.
The transactions were executed on Friday at an average price of Rs 2,826.60 per share, taking the combined value of the stake sale to around Rs 2,121.50 crore.
Fosun Pharma Reduces Stake in Gland Pharma
The latest transaction represents a 4.55 per cent stake in Gland Pharma. The shares were sold through separate block deals on the Bombay Stock Exchange.
Fosun Pharma Industrial Pte Ltd is among the promoters of Gland Pharma, which is headquartered in Hyderabad and operates in the pharmaceutical sector.
The stake sale marks another reduction in the promoter’s holding in the Indian drugmaker.
Rs 2,121 Crore Block Deal
According to details of the transactions, Fosun Pharma Industrial sold 75.05 lakh shares across 11 tranches.
At an average transaction price of Rs 2,826.60 per share, the deal was valued at approximately Rs 2,121.50 crore.
Block deals involve large quantities of shares being traded through a separate trading window and are commonly used by institutional investors and large shareholders to execute sizeable transactions.
Gland Pharma Shares in Focus
The stake sale is likely to keep Gland Pharma shares in focus as investors assess the implications of the promoter-level transaction.
Large promoter stake sales can attract market attention because they may influence investor sentiment and alter the company’s shareholding structure.
However, the transaction itself does not necessarily indicate any change in the company’s underlying business operations.
Fosun Pharma’s Position in Indian Pharma
Fosun Pharma has been associated with Gland Pharma as a promoter and has maintained a significant presence in the Indian pharmaceutical market through its investment in the company.
Gland Pharma is known for its focus on injectable pharmaceuticals and operates across regulated international markets.
The latest stake sale highlights the continuing movement of strategic and promoter holdings within India’s listed pharmaceutical sector.
Details of the Transaction
- Seller: Fosun Pharma Industrial Pte Ltd
- Company: Gland Pharma
- Stake Sold: 4.55 per cent
- Shares Sold: 75,05,500
- Number of Tranches: 11
- Average Price: Rs 2,826.60 per share
- Transaction Value: Rs 2,121.50 crore
- Exchange: BSE
- Transaction Type: Block Deals
The stake sale is expected to remain a key development for investors tracking Gland Pharma and promoter holding changes in India’s pharmaceutical sector.
(Economy India)
